Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katie D Stewart

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 23, 2023
Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 DiabetesKristina S Boye, Katie D Stewart, Louis S Matza
Journal of Patient-Reported Outcomes|September 6, 2023
Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetesKatie D Stewart, Louis S Matza, Hiren Patel, et al.
Journal of Patient-Reported Outcomes|June 1, 2026
Development of the Pediatric Type 2 Diabetes Impact Measure (P-TIM)Kristina S Boye, Katie D Stewart, Louis S Matza, et al.
Multiple Sclerosis and Related Disorders|August 23, 2019
Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)Louis S Matza, Katie D Stewart, Glenn Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Vignette-Based Utilities: Usefulness, Limitations, and Methodological RecommendationsLouis S Matza, Katie D Stewart, Andrew J Lloyd, et al.
BMC Health Services Research|November 28, 2017
Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetesLouis S Matza, Kristina S Boye, Katie D Stewart, et al.
The Patient|May 5, 2022
Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 DiabetesLouis S Matza, Katie D Stewart, Laura Fernández Landó, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Health State Utilities Associated with Glucose Monitoring DevicesLouis S Matza, Katie D Stewart, Evan W Davies, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 13, 2019
Health state utilities associated with treatment for transfusion-dependent β-thalassemiaLouis S Matza, L Clark Paramore, Katie D Stewart, et al.
Journal of Patient-Reported Outcomes|October 9, 2018
Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)Louis S Matza, Kristina S Boye, Katie D Stewart, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 23, 2023
Development of a Patient-Reported Outcome (PRO) Measure to Assess Emotional Impact of Treatment for Type 2 DiabetesKristina S Boye, Katie D Stewart, Louis S Matza
Journal of Patient-Reported Outcomes|September 6, 2023
Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetesKatie D Stewart, Louis S Matza, Hiren Patel, et al.
Journal of Patient-Reported Outcomes|June 1, 2026
Development of the Pediatric Type 2 Diabetes Impact Measure (P-TIM)Kristina S Boye, Katie D Stewart, Louis S Matza, et al.
Multiple Sclerosis and Related Disorders|August 23, 2019
Development of a brief clinician-reported outcome measure of multiple sclerosis signs and symptoms: The Clinician Rating of Multiple Sclerosis (CRoMS)Louis S Matza, Katie D Stewart, Glenn Phillips, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 13, 2021
Vignette-Based Utilities: Usefulness, Limitations, and Methodological RecommendationsLouis S Matza, Katie D Stewart, Andrew J Lloyd, et al.
BMC Health Services Research|November 28, 2017
Health state utilities associated with attributes of weekly injection devices for treatment of type 2 diabetesLouis S Matza, Kristina S Boye, Katie D Stewart, et al.
The Patient|May 5, 2022
Exit Interviews Examining the Patient Experience in Clinical Trials of Tirzepatide for Treatment of Type 2 DiabetesLouis S Matza, Katie D Stewart, Laura Fernández Landó, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Health State Utilities Associated with Glucose Monitoring DevicesLouis S Matza, Katie D Stewart, Evan W Davies, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|December 13, 2019
Health state utilities associated with treatment for transfusion-dependent β-thalassemiaLouis S Matza, L Clark Paramore, Katie D Stewart, et al.
Journal of Patient-Reported Outcomes|October 9, 2018
Development of the Diabetes Injection Device Experience Questionnaire (DID-EQ) and Diabetes Injection Device Preference Questionnaire (DID-PQ)Louis S Matza, Kristina S Boye, Katie D Stewart, et al.
Pageof 4